L-826791

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameL-826791

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionCaspase inhibitors

TargetsCaspase

Therapy Area/IndicationsCraniocerebral Trauma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Frosst Company

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Frosst Company

Active IndicationsN/A

Inactive IndicationsCraniocerebral Trauma

Other Information

ATC CodeN/A

Related LinksN/A